Abstract a-Synuclein is involved in many important molecular processes in neuronal cells and their synapses, and its malfunction has been linked to the development of Parkinson's and certain other neurodegenerative diseases. Animal models allowing tightly monitored conditional inactivation of the encoding gene, Snca, are indispensible for studies aimed at understanding normal function of a-synuclein in various neuronal populations and its role in pathogenesis of neurodegenerative diseases. We have recently reported the production of several novel mouse lines for manipulating expression of the endogenous Snca gene, including a line for Crerecombinase-driven conditional inactivation of the gene (mice with floxed Snca) and a new line with a constitutive knockout of a-synuclein. Rosa26-stoplacZ reporter cassette is commonly used for monitoring efficiency of Cre-recombination but in mouse genome Snca and Rosa26 loci are located on the same chromosome. Here we describe production of lines with a modified Snca locus, either floxed or constitutively inactivated and the Rosa26-stop-lacZ reporter cassette located in cis on the mouse chromosome 6. These new mouse lines are invaluable for fast identification of cells with inactivation of Snca by Crerecombination and represent useful tools for in vivo studies of a-synuclein function and dysfunction.
Introduction
Several missense mutations altering physico-chemical properties of a-synuclein as well as increased production of a-synuclein caused by duplications and triplications of the genomic region containing encoding gene, SNCA, have been associated with the development of familial forms of Parkinson's disease (PD) and related disorders (Polymeropoulos et al. 1997; Kruger et al. 1998; Singleton et al. 2003; Zarranz et al. 2004; ChartierHarlin et al. 2004; Ibanez et al. 2004; Proukakis et al. 2013; Appel-Cresswell et al. 2013; Kiely et al. 2013; Lesage et al. 2013) . Moreover, Lewy bodies and Lewy neurites, histopathological hallmarks of both hereditary and idiopathic forms of PD, are built on a scaffold of aggregated and fibrillated a-synuclein (Spillantini et al. 1997 (Spillantini et al. , 1998 . Genome-wide associated and case-control studies also linked a-synuclein to idiopathic and familial forms of PD as well as other synucleinopathies (Kay et al. 2008; Mizuta et al. 2008; Pankratz et al. 2009; Scholz et al. 2009; Sutherland et al. 2009 ).
It is still not clear how altered a-synuclein metabolism triggers the development of pathological changes in these neurodegenerative diseases. The gainof-function hypothesis is based on multiple evidence of the toxicity of intermediate products of a-synuclein aggregation, oligomers and protofibrils. However, asynuclein is important for structural and functional integrity of vertebrate neurons and/or their synapses (reviewed in Venda et al. 2010 ) and pathological aggregation of this protein might cause significant depletion of its functional pool in neurons and particularly in presynaptic terminals. Therefore, a contribution of a-synuclein loss-of-function mechanism to molecular pathogenesis of synucleinopathies cannot be discounted, despite no obvious signs of neurodegeneration have been observed in studies of constitutive a-synuclein knockout mice [reviewed in Buchman and Ninkina (2008) ]. These discouraging results can be explained by efficient mechanisms compensating to the loss of a-synuclein. It has been suggested that this compensation takes place in the developing nervous system during a period of its high plasticity (Al-Wandi et al. 2010 ). Depletion of a-synuclein in adult or ageing nervous system might be significantly more deleterious. To test this hypothesis an experimental system allowing conditional inactivation of a-synuclein encoding gene is required. Moreover, such system would be invaluable for assessing a-synuclein function in specific neuronal populations as well as in studies of a-synuclein aggregation pathology propagation through the nervous system.
Conditional gene knockout in mice requires a core mouse line with the gene of interest or its fragment surrounded by recognition sites for certain specific recombinases, most commonly Cre or FRT, and a transgenic mouse line expressing this recombinase in the particular type of cells. It is important to monitor the efficiency and specificity of recombination and to achieve this a reporter gene whose activation by a recombination event driven by the same enzyme can be easily detected, is also introduced in the animal genome. For monitoring Cre-loxP recombination a Rosa26-stop-lacZ reporter cassette is widely used. This reporter is usually delivered by another mouse line carrying a loxP-flanked transcription STOP sequence, which prevents expression of the downstream bacterial lacZ gene encoding b-galactosidase (Soriano 1999) . Activation of Cre-recombinase in a cell carrying both the reporter and the floxed gene of interest leads to simultaneous deletion of both floxed genomic fragments leading to inactivation of the studied gene and activation of lacZ expression, the latter can be readily detected due to accumulation of a colored product of b-galactosidase activity in cells when specific substrates are added to tissue samples.
We intended to use the Rosa26-stop-lacZ reporter to monitor conditional inactivation of a-synuclein coding gene (Snca) in mice carrying this gene with loxP-flanked first coding exon [Snca flox ] (Ninkina et al. 2015) and tamoxifen-activated Cre-recombinase (Cre/ ERT2) under control of various neuron-specific promoters but this was obscured by co-localisation of Snca and ROSA26 loci on the same mouse chromosome 6. To overcome this obstacle we have previously produced and used a mouse line with Rosa26-stoplacZ cassette and permanently inactivated Snca gene (Abeliovich et al. 2000 ) located on the same chromosome in cis. Here we describe a similar line but with a version of permanent Snca gene knockout that lack problems associated with the presence of Neo cassette in the genome of mice produced by Abeliovich et al. (2000) , for example dramatic overexpression of Mmrn1 gene (Ninkina et al. 2015) . We also produced a mouse line that carries Snca flox gene and Rosa26-stop-lacZ reporter cassette located in cis at the mouse chromosome 6. These lines represent useful tools for production of large cohorts of experimental animals for conditional inactivation of a-synuclein function.
Materials and methods

Animals
All animals were on C57Bl6J genetic background. Animal work was carried out in accordance with the United Kingdom (Scientific Procedures) Act (1986) 
Genotyping
Genomic DNA was isolated from mouse ear biopsies as described elsewhere (Ninkina et al. 2009 
Western blot analysis
Total protein extraction from mouse neuronal tissues, SDS-PAGE separation, semi-dry transfer, blocking, incubation with antibodies, washing and detection using enhanced chemiluminescence were carried out as described previously (Anwar et al. 2011 ). Antibodies against a-synuclein (mouse monoclonal, clone 42, BD Transduction Laboratories, diluted 1:500) and b-actin (mouse monoclonal, clone AC-15, Sigma diluted 1:5000) were used.
Detection of b-galactosidase activity in brain slices [Snca flox _Rosa26 mod /Snca flox _Rosa26 mod ] mice were crossed with transgenic mice expressing Cre-ERT2 under control of neurospecific NSE promoter (obtained from Jean C. Manson, The Roslin Institute, University of Edinburgh) and at the age of 3 month resulting F1 animals were injected intraperitoneally with tamoxifen (Sigma-Aldrich) dissolved in corn oil for five consecutive days (daily dose 75 mg/kg). One month after activation of Cre recombination by tamoxifen brains were dissected and transverse slices (*1 mm thick) through the brainstem were processed and stained for b-galactosidase activity using X-gal as a substrate as described elsewhere (Burn 2012) .
Results and discussion
Within our previous breeding programme a mouse founder has been obtained that carried a permanently inactivated Snca locus from mice originally produced by Abeliovich et al. (2000) and Rosa26-stop-lacZ cassette (Soriano 1999) on the same chromosome 6 in cis. As the physical distance between Snca and Rosa26 loci is 52.3 Mb, which constitutes more than one-third of total 150 Mb length of mouse chromosome 6 (Fig. 1) , and genetic distance is 23.5 cM, high meiotic recombination frequency between these loci is expected. Therefore we decided to carry out additional breeding programme aimed for obtaining mouse lines carrying other genetic modifications of Snca gene in cis with Rosa26-stop-lacZ reporter cassette.
The deletion of the Snca exon 2 (first coding exon) by Cre-loxP recombination in the germline causes complete arrest of a-synuclein production in homozygous Snca -/Snca -mice. This genomic modification does not affect expression of neighboring genes, e.g. Mmrn1 (Ninkina et al. 2015) , which is a drawback for the knockout mice produced by Abeliovich et Transgenic Res (2017) 26:301-307 303 Fig. 2 A sheme of the breeding protocol that produced mouse founders carrying a constituent knock-out of a-synucleinencoding gene (exon-2) and Rosa26-stop-lacZ cassette located in cis on mouse chromosome 6 as the result of meiotic recombination (a). PCR amplification approach used for identification of modifications in Snca (b) and Rosa26 (c) loci. Position of primers within these loci and analysis of corresponding amplification products in agarose gel are shown genotype were intercrossed (Fig. 2a) . F2 offsprings were genotyped for both loci (Fig. 2b, c Fig. 2a) , which was not consistent with classical Mendelian inheritance that predicts segregation of chromosomes and independent assortment of alleles. Most probably this genotype appeared as a result of a reciprocal recombination between chromosome 6 bearing Rosa26-stop-lacZ cassette and chromosome 6 bearing Snca null mutant gene during meiosis I phase of gametogenesis leading to non-Mendelian segregation of traits. Consequently, a male mouse that became a founder of a new line carried a chromosome 6 with both ] mice led to expression of lacZ gene from the modified Rosa26 locus (Fig. 4b) .
Two new transgenic mouse lines produced in this study complement a set of previously described mouse lines (Ninkina et al. 2015) for manipulating endogenous a-synuclein expression and makes generation of experimental cohorts for experiments required conditional inactivation of a-synuclein function relatively easy and straightforward.
For example, it is sufficient to obtain mice carrying a copy of relevant Cre-recombinase along with a copy In conclusion, we produced two mouse lines that constitute novel useful tools for studying normal function of a-synuclein and its role in pathological processes. 
